- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 453/04 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
Patent holdings for IPC class C07D 453/04
Total number of patents in this class: 73
10-year publication summary
|
6
|
12
|
0
|
6
|
2
|
3
|
5
|
5
|
4
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BRANDEIS University | 332 |
5 |
| Syngenta Participations AG | 1730 |
3 |
| Chiesi Farmaceutici S.p.A. | 973 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 605 |
3 |
| Nectar Health Sciences Inc. | 11 |
3 |
| Boehringer Ingelheim International GmbH | 4636 |
2 |
| Janssen Pharmaceutica N.V. | 3358 |
2 |
| Research Cooperation Foundation of Yeungnam University | 193 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 849 |
2 |
| Sungkyunkwan University Foundation for Corporate Collaboration | 235 |
2 |
| UPL Limited | 608 |
2 |
| Boehringer Ingelheim Animal Health USA Inc. | 421 |
2 |
| Merck Sharp & Dohme LLC | 3732 |
2 |
| BASF SE | 21098 |
1 |
| Sandoz AG | 1411 |
1 |
| The Regents of the University of California | 20303 |
1 |
| Merck Sharp & Dohme Corp. | 2189 |
1 |
| Sanofi-Aventis Deutschland GmbH | 2611 |
1 |
| Janssen Pharmaceuticals, Inc. | 442 |
1 |
| Ortho-mcneil-janssen Pharmaceuticals, Inc. | 20 |
1 |
| Other owners | 33 |